Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care
Journal of Palliative Medicine · 2024
DOI: 10.1089/jpm.2024.0153 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Palliative Medicine, 2024. Verfasst von Rita Ostan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Training and Research Department, National Tumor Assistance (ANT), Bologna, Italy. Hauptthemen laut MEDLINE: Erythrocyte Transfusion, Neoplasms, Palliative Care, Home Care Services. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Themen: Palliativpflege
Abstract (Originalsprache)
Background
Red blood cell (RBC) transfusion is the standard treatment for anemia in advanced cancer. Nevertheless, guidelines for managing this condition are still not exhaustive.
Objective
To investigate frequency, timing, and clinical characteristics associated with RBC transfusions in patients with advanced cancer assisted by at-home oncological care service and to evaluate the association between parameters at the entry and the possibility of receiving RBC transfusions during homecare.
Design
Retrospective observational study without medication. Setting/Subjects: Patients with advanced cancer entered in homecare during 2021 living in Bologna (Italy).
Measurements
Gender, tumor primary site, oncological therapy, and symptoms at the entry were considered as possible factors in a binary logistic regression for the possibility of receiving at least one RBC transfusion during assistance. Data about transfusions were analyzed, and the transfusion history for each patient from the entry to death was traced.
Results
Among the 1108 patients admitted, 179 (16.2%) were given at least one RBC transfusion during homecare. Genitourinary, hematological malignancies, and being still in therapy for advanced cancer are associated with a higher probability of receiving RBC transfusion during assistance (p = 0.017, p < 0.001, and p = 0.032, respectively). Half of the patients (52%) underwent RBC transfusions less than a month before death. Duration of the assistance was correlated with the period from last transfusion to death (p < 0.001).
Conclusion
Hematological and genitourinary cancer and being in simultaneous care at the entry were associated with transfusion. Although the appropriateness of this treatment remains to be defined in this population, transfused patients frequently received "late in life" transfusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Training and Research Department, National Tumor Assistance (ANT), Bologna, Italy.
- Department of Palliative Care, Rehabilitation and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Zitieren
APA
Ostan, R., Varani, S., Yaaqovy, A. D., Patrignani, M., Pannuti, R., Bruera, E., & Biasco, G. (2024). Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2024.0153
Vancouver
Ostan R, Varani S, Yaaqovy AD, Patrignani M, Pannuti R, Bruera E, et al. Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care. Journal of Palliative Medicine. 2024. doi:10.1089/jpm.2024.0153
BibTeX
@article{Ostan2024,
author = {Ostan, Rita and Varani, Silvia and Yaaqovy, Ahikam David and Patrignani, Monica and Pannuti, Raffaella and Bruera, Eduardo and Biasco, Guido},
title = {Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care},
journal = {Journal of Palliative Medicine},
year = {2024},
doi = {10.1089/jpm.2024.0153}
}
EUVIMED